MDLZMarch 2, 2026 at 1:10 PM UTCFood, Beverage & Tobacco

Mondelez's Tepid 2026 Growth Guidance Underscores Persistent Volume and Cost Headwinds

Read source article

What happened

In 2025, Mondelez achieved 4.3% organic revenue growth solely through aggressive pricing to offset record cocoa inflation, as noted in a recent article. However, the DeepValue report reveals this pricing came at a steep cost, with global volume/mix deteriorating by -3.2 points in 9M 2025 due to consumer down-trading and elasticity. For 2026, management now targets only flat to 2% organic growth, citing soft demand, which contrasts with earlier optimism for a stronger recovery as cocoa costs ease. This guidance signals that the volume erosion and broader input pressures documented in filings—such as tariffs and other inflation—are more severe than the company's upbeat narrative suggests. Consequently, the anticipated margin rebound from cocoa deflation may be muted by ongoing volume weakness, challenging the high-single-digit EPS growth embedded in current valuations.

Implication

The lowered 2026 growth target implies that Mondelez's earnings recovery will be delayed, as volume declines offset any benefits from cocoa cost relief. Persistent negative volume/mix across regions highlights elevated consumer elasticity, limiting pricing power and threatening market share. Broader inflation in inputs like dairy, packaging, and tariffs could sustain cost pressures, eroding gross margin gains even as cocoa prices fall. Management's aggressive capital returns, while supportive, may become unsustainable if cash flow weakens further from these operational challenges. Therefore, investors should wait for concrete evidence of volume stabilization and margin improvement before considering new positions, aligning with the DeepValue report's 'WAIT' rating.

Thesis delta

The new 2026 guidance of flat to 2% organic growth reinforces the DeepValue report's caution, shifting the thesis toward a more bearish outlook where volume and cost pressures persist longer than expected. This increases the probability that EPS growth will track in the low-to-mid single digits rather than the high-single-digit trajectory implied by current valuations, emphasizing the need for a lower entry price or clearer proof of recovery.

Confidence

High